STING1 and pancreatic neoplasm: For example, Zhang et al. showed that in pancreatic cancer models, inhibition of ATM leads to increased Type I interferon signaling in a cGAS–STING-independent fashion, resulting in enhanced PD-L1 expression, increased CD8+ T-cell infiltration and ultimately in improved responses to immune checkpoint therapy [82].